DIA 2025 Global Annual Meeting

Component Type: Session
Level: Advanced

This session will explore how Intelligent Automation (IA) and AI are transforming R&D and Regulatory Affairs by automating document-heavy processes and driving data-driven decisions. Through real-world use cases presented by industry sponsors, attendees will learn how IA and AI are being applied to improve efficiencies, reduce timelines, and optimize regulatory outcomes.

Learning Objectives

Understand AI applications in drug discovery, clinical trials, regulatory, manufacturing, and pharmacovigilance; Explore practical use cases of AI in Regulatory Operations; Discuss advancing fit-for-purpose, risk-based frameworks for AI and global regulatory alignment.

Chair

Venkatraman Balasubramanian, PhD, MBA

Speaker

AI Innovation in Drug Development: Cutting-Edge Use Cases and Regulatory Insights
Kevin Bugin, PhD, MS, RAC